257 related articles for article (PubMed ID: 3081635)
1. Regulation of the alternative pathway of T cell activation by anti-T3 monoclonal antibody.
Fox DA; Schlossman SF; Reinherz EL
J Immunol; 1986 Mar; 136(6):1945-50. PubMed ID: 3081635
[TBL] [Abstract][Full Text] [Related]
2. Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations.
Fox DA; Hussey RE; Fitzgerald KA; Bensussan A; Daley JF; Schlossman SF; Reinherz EL
J Immunol; 1985 Jan; 134(1):330-5. PubMed ID: 2578045
[TBL] [Abstract][Full Text] [Related]
3. The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells.
Breitmeyer JB; Daley JF; Levine HB; Schlossman SF
J Immunol; 1987 Nov; 139(9):2899-905. PubMed ID: 2444644
[TBL] [Abstract][Full Text] [Related]
4. Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen-dependent and antigen-independent pathways of human T cell activation.
Moretta A; Olive D; Poggi A; Pantaleo G; Mawas C; Moretta L
Eur J Immunol; 1986 Nov; 16(11):1427-32. PubMed ID: 2430811
[TBL] [Abstract][Full Text] [Related]
5. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
6. Effect of T3 modulation on pokeweed mitogen-induced T cell activation: evidence for an alternative pathway of T cell activation.
Ceuppens JL; Meurs L; Baroja ML; Van Wauwe JP
J Immunol; 1986 May; 136(9):3346-50. PubMed ID: 3007616
[TBL] [Abstract][Full Text] [Related]
7. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
Schwab R; Crow MK; Russo C; Weksler ME
J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
[TBL] [Abstract][Full Text] [Related]
8. Clonal analysis of the involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions.
Moretta A; Pantaleo G; Lopez-Botet M; Carrel S; Moretta L
Behring Inst Mitt; 1985 Aug; (77):39-47. PubMed ID: 2417584
[TBL] [Abstract][Full Text] [Related]
9. T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.
Brottier P; Boumsell L; Gelin C; Bernard A
J Immunol; 1985 Sep; 135(3):1624-31. PubMed ID: 2410496
[TBL] [Abstract][Full Text] [Related]
10. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
Yang SY; Chouaib S; Dupont B
J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
[TBL] [Abstract][Full Text] [Related]
11. A novel 90-kDa polypeptide (Tp90) possibly involved in an antigen-independent pathway of T cell activation.
Carrel S; Salvi S; Giuffrè L; Isler P; Cerottini JC
Eur J Immunol; 1987 Jun; 17(6):835-41. PubMed ID: 3036540
[TBL] [Abstract][Full Text] [Related]
12. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.
Hünig T; Tiefenthaler G; Meyer zum Büschenfelde KH; Meuer SC
Nature; 1987 Mar 19-25; 326(6110):298-301. PubMed ID: 3102975
[TBL] [Abstract][Full Text] [Related]
13. Involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions: effect of anti-T11 monoclonal antibody on functional capabilities of alloreactive T cell clones.
Moretta A; Pantaleo G; Lopez-Botet M; Mingari MC; Carrel S; Moretta L
Eur J Immunol; 1985 Aug; 15(8):841-4. PubMed ID: 3161746
[TBL] [Abstract][Full Text] [Related]
14. Activation of immature cortical thymocytes through the T11 sheep erythrocyte binding protein.
Blue ML; Daley JF; Levine H; Craig KA; Schlossman SF
J Immunol; 1987 May; 138(10):3108-13. PubMed ID: 3033069
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptors and corticosensitivity of human thymocytes at discrete stages of intrathymic differentiation.
Ranelletti FO; Maggiano N; Aiello FB; Carbone A; Larocca LM; Musiani P; Piantelli M
J Immunol; 1987 Jan; 138(2):440-5. PubMed ID: 3098842
[TBL] [Abstract][Full Text] [Related]
16. Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway.
Scott CF; Lambert JM; Kalish RS; Morimoto C; Schlossman SF
J Immunol; 1988 Jan; 140(1):8-14. PubMed ID: 2891767
[TBL] [Abstract][Full Text] [Related]
17. T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2.
Huet S; Wakasugi H; Sterkers G; Gilmour J; Tursz T; Boumsell L; Bernard A
J Immunol; 1986 Sep; 137(5):1420-8. PubMed ID: 2427570
[TBL] [Abstract][Full Text] [Related]
18. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
Ceuppens JL; Bloemmen FJ; Van Wauwe JP
J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
[TBL] [Abstract][Full Text] [Related]
19. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
